DD297838A5 - Verfahren zum einfuehren von genetischen einheiten in die zelle - Google Patents
Verfahren zum einfuehren von genetischen einheiten in die zelle Download PDFInfo
- Publication number
- DD297838A5 DD297838A5 DD90338709A DD33870990A DD297838A5 DD 297838 A5 DD297838 A5 DD 297838A5 DD 90338709 A DD90338709 A DD 90338709A DD 33870990 A DD33870990 A DD 33870990A DD 297838 A5 DD297838 A5 DD 297838A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- rna
- ribozyme
- genetic
- genetic unit
- trna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT60989 | 1989-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD297838A5 true DD297838A5 (de) | 1992-01-23 |
Family
ID=3495118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD90338709A DD297838A5 (de) | 1989-03-16 | 1990-03-14 | Verfahren zum einfuehren von genetischen einheiten in die zelle |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0387775B1 (pt) |
JP (1) | JP3330930B2 (pt) |
KR (1) | KR900014591A (pt) |
AT (1) | ATE140961T1 (pt) |
AU (1) | AU637354B2 (pt) |
CA (1) | CA2012312C (pt) |
DD (1) | DD297838A5 (pt) |
DE (1) | DE59010432D1 (pt) |
DK (1) | DK0387775T3 (pt) |
ES (1) | ES2090049T3 (pt) |
FI (1) | FI105103B (pt) |
GR (1) | GR3020935T3 (pt) |
HU (2) | HU215187B (pt) |
IE (1) | IE74850B1 (pt) |
IL (1) | IL93754A (pt) |
NO (1) | NO306623B1 (pt) |
NZ (1) | NZ232917A (pt) |
PT (1) | PT93440B (pt) |
RU (1) | RU2136751C1 (pt) |
ZA (1) | ZA901973B (pt) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0471796A4 (en) * | 1989-05-10 | 1993-05-05 | Sloan Kettering Institute For Cancer Research | Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
DE4091533T (pt) * | 1989-08-31 | 1992-01-30 | ||
JP2507895B2 (ja) * | 1989-12-19 | 1996-06-19 | 工業技術院長 | リボザイムの新規合成系 |
WO1991019789A1 (en) * | 1990-06-19 | 1991-12-26 | Commonwealth Scientific And Industrial Research Organisation | Endonucleases |
US6008343A (en) * | 1990-06-19 | 1999-12-28 | Gene Shears Pty. Ltd. | Nucleotide based endonucleases |
DE69123979T2 (de) * | 1990-10-12 | 1997-04-30 | Max Planck Gesellschaft | Abgeänderte ribozyme |
DE4104186A1 (de) * | 1991-02-12 | 1992-08-13 | Genentech Inc | Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe |
FR2687411A1 (fr) * | 1992-02-13 | 1993-08-20 | Nice Sophia Antipolis Universi | Vecteur comportant un gene viral transcrit par l'arn polymerase iii, et procede de production intracellulaire d'arn. |
WO1993022433A2 (de) * | 1992-04-28 | 1993-11-11 | Frank Andreas Harald Meyer | Medikament zur gentherapeutischen behandlung von menschen, tieren und pflanzen, insbesondere zur blockierung der virenvermehrung und der tumorgene sowie verfahren zur herstellung des medikaments |
EP0641212A4 (en) * | 1992-05-14 | 1997-05-21 | Ribozyme Pharm Inc | PROCESS AND REAGENT FOR PREVENTING THE DEVELOPMENT OF CANCER. |
US5610052A (en) * | 1992-08-26 | 1997-03-11 | Ribozyme Pharmaceuticals Inc. | Enzymatic RNA with activity to ras |
US5989906A (en) * | 1992-05-14 | 1999-11-23 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting P-glycoprotein (mdr-1-gene) |
WO1993024133A1 (en) * | 1992-05-27 | 1993-12-09 | City Of Hope | CHIMERIC tRNALYS-RIBOZYME MOLECULES |
US5827935A (en) * | 1992-05-27 | 1998-10-27 | City Of Hope | Chimeric tRNAlys -ribozyme molecules |
DE69333937T2 (de) * | 1992-06-29 | 2006-08-31 | Gene Shears Pty. Ltd. | Nukleinsäuren und sie verwendende verfahren zur bekämpfung viraler pathogene |
WO1994013798A1 (en) * | 1992-12-16 | 1994-06-23 | Bergmann Johanna E | Agents for the prevention and treatment of human alzheimer's disease |
EP0647716B1 (fr) * | 1993-07-06 | 2003-09-24 | Universite De Nice-Sophia Antipolis | Vecteur comportant un gène viral transcrit par l'ARN polymérase III |
US5837503A (en) * | 1993-07-07 | 1998-11-17 | Universite De Nice-Sophia-Antipolis | Vector containing viral gene transcribed by RNA polymerase III and methods for use |
US5817635A (en) * | 1993-08-09 | 1998-10-06 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Modified ribozymes |
EP0707493A4 (en) * | 1994-01-24 | 1999-03-31 | Hope City | COLOLIZATION OF TARGET MOLECULE AND ITS INHIBITOR |
DE4424761C1 (de) * | 1994-07-04 | 1995-06-08 | Max Planck Gesellschaft | Expressionskassette für die Antisense- und die Ribozym-Expression |
JPH11506914A (ja) | 1995-06-07 | 1999-06-22 | コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼーション | 最適化ミニザイムおよびミニリボザイムおよびその使用 |
FR2755976B1 (fr) | 1996-11-15 | 1999-01-15 | Idm Immuno Designed Molecules | Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires |
US6057156A (en) | 1997-01-31 | 2000-05-02 | Robozyme Pharmaceuticals, Inc. | Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors |
AU1187099A (en) * | 1997-10-21 | 1999-05-10 | Ribozyme Pharmaceuticals, Inc. | Peptide bond formation using nucleic acid catalysts |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
CN101818145A (zh) | 1998-03-20 | 2010-09-01 | 联邦科学和工业研究组织 | 控制基因表达 |
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
EP1147204A1 (en) | 1999-01-28 | 2001-10-24 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
EP1229134A3 (en) | 2001-01-31 | 2004-01-28 | Nucleonics, Inc | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
AUPR621501A0 (en) | 2001-07-06 | 2001-08-02 | Commonwealth Scientific And Industrial Research Organisation | Delivery of ds rna |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4987071A (en) * | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
-
1990
- 1990-03-13 DK DK90104701.9T patent/DK0387775T3/da active
- 1990-03-13 AT AT90104701T patent/ATE140961T1/de not_active IP Right Cessation
- 1990-03-13 EP EP90104701A patent/EP0387775B1/de not_active Expired - Lifetime
- 1990-03-13 ES ES90104701T patent/ES2090049T3/es not_active Expired - Lifetime
- 1990-03-13 DE DE59010432T patent/DE59010432D1/de not_active Expired - Lifetime
- 1990-03-14 HU HU901584A patent/HU215187B/hu unknown
- 1990-03-14 NZ NZ232917A patent/NZ232917A/en unknown
- 1990-03-14 DD DD90338709A patent/DD297838A5/de not_active IP Right Cessation
- 1990-03-15 PT PT93440A patent/PT93440B/pt not_active IP Right Cessation
- 1990-03-15 IL IL9375490A patent/IL93754A/en not_active IP Right Cessation
- 1990-03-15 NO NO901213A patent/NO306623B1/no not_active IP Right Cessation
- 1990-03-15 AU AU51301/90A patent/AU637354B2/en not_active Expired
- 1990-03-15 KR KR1019900003438A patent/KR900014591A/ko not_active Application Discontinuation
- 1990-03-15 CA CA002012312A patent/CA2012312C/en not_active Expired - Lifetime
- 1990-03-15 FI FI901296A patent/FI105103B/fi active IP Right Grant
- 1990-03-15 JP JP06549390A patent/JP3330930B2/ja not_active Expired - Lifetime
- 1990-03-15 IE IE93190A patent/IE74850B1/en not_active IP Right Cessation
- 1990-03-15 ZA ZA901973A patent/ZA901973B/xx unknown
- 1990-03-16 RU SU5010032A patent/RU2136751C1/ru active
-
1995
- 1995-06-30 HU HU95P/P00692P patent/HU211868A9/hu unknown
-
1996
- 1996-09-03 GR GR960402292T patent/GR3020935T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT93440A (pt) | 1990-11-07 |
IE74850B1 (en) | 1997-08-13 |
CA2012312A1 (en) | 1990-09-16 |
IL93754A0 (en) | 1990-12-23 |
ZA901973B (en) | 1991-11-27 |
NO901213D0 (no) | 1990-03-15 |
EP0387775A1 (de) | 1990-09-19 |
NZ232917A (en) | 1997-07-27 |
IE900931L (en) | 1990-09-16 |
AU5130190A (en) | 1990-11-01 |
FI901296A0 (fi) | 1990-03-15 |
HU215187B (hu) | 1998-10-28 |
DE59010432D1 (de) | 1996-09-05 |
EP0387775B1 (de) | 1996-07-31 |
DK0387775T3 (da) | 1996-11-04 |
HU901584D0 (en) | 1990-06-28 |
HU211868A9 (en) | 1995-12-28 |
AU637354B2 (en) | 1993-05-27 |
ATE140961T1 (de) | 1996-08-15 |
PT93440B (pt) | 2001-07-31 |
RU2136751C1 (ru) | 1999-09-10 |
KR900014591A (ko) | 1990-10-24 |
NO306623B1 (no) | 1999-11-29 |
JPH03130080A (ja) | 1991-06-03 |
GR3020935T3 (en) | 1996-12-31 |
FI105103B (fi) | 2000-06-15 |
JP3330930B2 (ja) | 2002-10-07 |
ES2090049T3 (es) | 1996-10-16 |
HUT54206A (en) | 1991-01-28 |
CA2012312C (en) | 2001-08-14 |
NO901213L (no) | 1990-09-17 |
IL93754A (en) | 1995-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0387775B1 (de) | Genetische Einheiten zur Inhibierung der Funktion von RNA | |
DE69121391T2 (de) | Methode zur ortsspezifischen änderung von rna und produktion von dadurch kodierten polypeptiden | |
EP0388758B1 (de) | Neue Protein-Polykation-Konjugate | |
DE69233117T2 (de) | In sich geschlossende "sens-" und "antisense"-oligonukleotide und deren verwendungen | |
DE3852539T3 (de) | Ribozyme. | |
DE69303712T2 (de) | Gezielte spaltung von rna mittels eukaryontischer rnase p und externe führungssequenz | |
DE69636937T2 (de) | Durch trans-spaltung erhaltene therapeutische molekule | |
DE69634698T2 (de) | Gewebespezifische und ziel-rna-spezifische ribozyme | |
DE69729292T2 (de) | Kurze externe führungssequenzen | |
DE69034238T2 (de) | Verfahren zur Erreichung einer Expression, oder zur Verbesserung der Expression eines Gens | |
DE3751567T2 (de) | Rns-ribozym restriktionsendoribonukleasen und verfahren. | |
DE69231739T2 (de) | Aus alternden zellen abgeleitete hemmer der dns-synthese | |
DE69126311T2 (de) | Therapeutische zusammensetzungen auf der basis von ribozymen | |
DE69433034T2 (de) | Expression von heterologen genen nach einem ziel-expressionsprofil | |
DE3855864T2 (de) | Durch modifikationen an der 3'-terminalen phosphodiesterbindung stabilisierte dna moleküle, ihre verwendung als nukleinsäuresonden sowie als therapeutische mittel zur hemmung der expression spezifischer zielgene | |
DE3486053T3 (de) | Regulierung von Gen-Expression durch Translationshemmung unter Verwendung von m-RNS hinderndem Komplementär-RNS. | |
DE69333550T2 (de) | TNF-alpha RIBOZYME UND ABBAU-RESISTENTE mRNA DERIVATIVE GEBUNDEN AN TNF-alpha Ribozyme | |
DE69729145T2 (de) | Reagenz und Verfahren zur Inhibierung der N-RAS Expression | |
WO2003062423A2 (de) | Verfahren zur hemmung der expression eines durch eine chromosomen-aberration entstandenen zielgens | |
DE60221572T2 (de) | Kontrolle der genexpression durch verwendung eines komplexes aus einem oligonucleotid und einem regulatorischen peptid | |
DE69620235T2 (de) | Antitumor-vektorkonstrukte und methoden | |
WO2003022858A2 (de) | Verfahren zum screenen von inhibitoren für die protein-protein-wechselwirkung sowie ribozyme hierzu | |
DE69432444T2 (de) | Promotor-Sequenz des Rezeptors p55 für Tumor-Nekrosis-Faktor | |
EP1259263B1 (de) | Komplexierung von rns, insbesondere von ribozymen, mit polyethyleniminen zu deren stabilisierung und zellulären einschleusung | |
DE69302369T2 (de) | Erhöhung der katalytischen Aktivität von Ribozymen mit einem benachbartem Oligonukleotid als Heffer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |